UnitedHealth Group Incorporated $UNH Shares Bought by Western Wealth Management LLC

Western Wealth Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,855 shares of the healthcare conglomerate’s stock after purchasing an additional 299 shares during the period. Western Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,763,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Elyxium Wealth LLC grew its holdings in UnitedHealth Group by 236.2% in the first quarter. Elyxium Wealth LLC now owns 1,819 shares of the healthcare conglomerate’s stock valued at $953,000 after purchasing an additional 1,278 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC raised its stake in shares of UnitedHealth Group by 8.2% during the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 395 shares of the healthcare conglomerate’s stock worth $207,000 after buying an additional 30 shares during the last quarter. Finally, Counterweight Ventures LLC grew its stake in UnitedHealth Group by 3.4% in the 1st quarter. Counterweight Ventures LLC now owns 5,662 shares of the healthcare conglomerate’s stock valued at $2,965,000 after acquiring an additional 187 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.1%

Shares of UnitedHealth Group stock opened at $325.50 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $622.83. The business has a 50-day moving average of $347.65 and a 200-day moving average of $318.79. The company has a market capitalization of $294.85 billion, a PE ratio of 16.95, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the business earned $7.15 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a $2.21 dividend. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Piper Sandler lowered their target price on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. TD Cowen upped their target price on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. KeyCorp lifted their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.